References
- Arango C, Bobes J. Managing acute exacerbations of schizophrenia: focus on quetiapine. Curr Med Res Opin 2004; 20: 619–626
- Cheer SM, Wagstaff AJ. Quetiapine. A review of its use in the management of schizophrenia. CNS Drugs 2004; 18: 173–199
- De Nayer A, Windhager E, Irmansyah, Larmo I, Lindenbauer B, Rittmannsberger H, Platz T, Jones AM, Whiteford JL, Altman CA. Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics. Int J Psychiatry Clin Pract 2003; 7: 59–70
- Dittmann RW, Meyer E, Freisleder FJ, et al submitted. Olanzapine pine is the treatment of adolescents with schizophrenia: results from a large, prospective, open-label study.
- Findling RL, McNamara NK. Atypical antipsychotics in the treatment of children and adolescents: clinical applications. J Clin Psychiatry 2004; 65(Suppl 6)30–44
- Freisleder FJ, Althoff A, Rüth U. Wirksamkeit und Verträglichkeit von Clozapin bei psychotischen Kindern und Jugendlichen. Clozapin – Pharmakologie und Klinik eines atypischen Neuroleptikums, D Naber, F Müller-Spahn. Springer, Berlin 1997; 23–31
- Guy W. ECDEU Assessment manual for psychopharmacology: Publication ADM 76–338. US Department of Health, Education, and Welfare, Washington, DC 1976; 218–222
- Marneros A, Deister A, Rohde A. Affektive, schizoaffektive und schizophrene Psychosen. Eine vergleichende Langzeitstudie. Springer, Berlin 1991
- McConville BJ, Arvanitis LA, Thyrum PT, Yeh C, Wilkinson LA, Chaney RO, Foster KD, Sorter MT, Friedman LM, Brown KL, Heubi JE. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders. J Clin Psychiatry 2000; 61: 252–260
- McConville B, Carrero L, Sweitzer D, Potter L, Chaney R, Foster K, Sorter M, Friedman L, Browne K. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial. J Child Adolesc Psychopharmacol 2003; 13: 75–82
- Schulz SC, Findling RL, Friedman L, Kenny JT, Wise AL. Treatment and outcomes in adolescents with schizophrenia. J Clin Psychiatry 1998; 59(Suppl 1)50–54
- Shaw JA, Lewis JE, Pascal S, Sharma RK, Rodriguez RA, Guillen R, Pupo-Guillen M. A study of quetiapine: efficacy and tolerability in psychotic adolescents. J Child Adolesc Psychopharmacol 2001; 11: 415–424
- Zimbroff DL. Management of acute psychosis: from emergency to stabilization. CNS Spectr 2003; 8(11 Suppl 2)10–15